We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer (CY503C2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00932724
Recruitment Status : Terminated (The sponsor declared the early termination of the study due to poor recruitment of patients.)
First Posted : July 3, 2009
Last Update Posted : July 10, 2013
ClinAssess GmbH
Medical University Innsbruck
Charite University, Berlin, Germany
Information provided by:
Cytavis Biopharma GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : August 2012
  Study Completion Date : August 2012